Qsemble Capital Management, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1766159 New York, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$4,773,504

-$879,900 QoQ

Shares Held

37,783

-6.9% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#592

of 2,266 holders

Holding Since

Dec 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qsemble Capital Management, LP holds $10,662,975 across 3 Drug Manufacturers - General names. GILD ranks #1 (44.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	37,783	$4,773,504
2	PFE	Pfizer Inc	122,644	$2,953,267
3	LLY	ELI LILLY & Co	2,448	$2,936,204

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,773,504	37,783	-6.9%	Shares	Sole	2026-08-03
2026-03-31	$5,653,404	40,564	+160.3%	Shares	Sole	2026-05-07
2025-09-30	$1,729,935	15,585	-0.2%	Shares	Sole	2025-11-13
2024-12-31	$1,442,449	15,616	-59.8%	Shares	Sole	2025-02-11
2024-06-30	$2,664,881	38,841	-3.8%	Shares	Sole	2024-08-07
2024-03-31	$2,959,007	40,396	+213.1%	Shares	Sole	2024-05-07
2023-03-31	$1,070,313	12,900	+158.0%	Shares	Sole	2023-05-10
2022-12-31	$429,250	5,000	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.